Trial NCT00571519

View at ClinicalTrials.gov 
Org. Study IDs: CS0011-A-U302

Last trial update was posted on 2021-05-26

MeSH Interventions

Metformin Pioglitazone

MeSH Conditions

Diabetes Mellitus Diabetes Mellitus, Type 2

Other Conditions

Type 2 Diabetes Mellitus

Stopping Reasons

DSPD focusing on Study 301 to confirm the clinical profile before proceeding. Daiichi Sankyo Pharma Development terminated this study on 23 Apr 2008 because of changes in the clinical development plan with 94 of 2600 planned, randomized participants.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID